DUSC report a good news story for patients: Expert

The PBAC has raised concerns that people with Crohn’s disease are staying on biologic medicines longer than expected, contributing to a blow-out in PBS costs. But an expert has told the limbic that the high rate of  biologic continuation was a positive sign that patients were responding well to treatment and getting on with their ...

Already a member?

Login to keep reading.

© 2021 the limbic